Billionaire Stanley Druckmiller has now assigned more than a billion dollars to three shares under the radar.
New Archives show The Duquesne family office of Druckmiller gambles great on shares in the technological and health care sector.
From the first quarter of 2025 the largest position of the company in Natera Inc. (Ntra), a technology company that specializes in genetic tests for the early detection of hereditary disorders such as cancer. Data shows that Duquesne now owns 3.402 million NTRA shares worth around $ 521,48 million.
The company also holds an important position in Teva Pharmaceutical Industries (TEVA), a manufacturer of generic medicines established in Israel. According to the submission, Duquesne has collected 14.879 million shares in TEVA worth around $ 252.955 million.
Druckenmiller has also invested heavily in the South Korean e-commerce Gigant Coupang Inc. (CPNG). The company has more than 9.3 million shares of CPNG worth around $ 252.659 million.
All in all, Duquesne Family Office has more than $ 1.02 billion in shares in Ntra, Teva and CPNG, represent 33% of the company’s portfolio of the company.
In addition to Ntra, Teva and CPNG, the best interests of Druckmiller are Woodward Inc. from the first quarter of this year (WWD) worth $ 226.13 million, Philip Morris International (PM) worth $ 193.67 million and Coherent (COHR) worth $ 175.27 million.
Meanwhile, the company reduced The importance in Seagate Technology (STX), Skechers USA (SKX), United Airlines (UAL) and SLM Corp (SLM) in Q1 2025.
Follow us on X” Facebook And Telegram
Don’t miss a beat – Subscribe to get e -mail notifications directly to your inbox
Check price promotion
Surf the Daily Hodl -Mix
Generated image: midjourney
